1. Home
  2. DSX vs URGN Comparison

DSX vs URGN Comparison

Compare DSX & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSX
  • URGN
  • Stock Information
  • Founded
  • DSX 1999
  • URGN 2004
  • Country
  • DSX Greece
  • URGN United States
  • Employees
  • DSX N/A
  • URGN N/A
  • Industry
  • DSX Marine Transportation
  • URGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSX Consumer Discretionary
  • URGN Health Care
  • Exchange
  • DSX Nasdaq
  • URGN Nasdaq
  • Market Cap
  • DSX 172.5M
  • URGN 181.2M
  • IPO Year
  • DSX 2005
  • URGN 2017
  • Fundamental
  • Price
  • DSX $1.59
  • URGN $15.27
  • Analyst Decision
  • DSX
  • URGN Strong Buy
  • Analyst Count
  • DSX 0
  • URGN 8
  • Target Price
  • DSX N/A
  • URGN $29.00
  • AVG Volume (30 Days)
  • DSX 271.2K
  • URGN 1.5M
  • Earning Date
  • DSX 07-30-2025
  • URGN 08-12-2025
  • Dividend Yield
  • DSX 2.42%
  • URGN N/A
  • EPS Growth
  • DSX N/A
  • URGN N/A
  • EPS
  • DSX 0.05
  • URGN N/A
  • Revenue
  • DSX $225,498,000.00
  • URGN $91,871,000.00
  • Revenue This Year
  • DSX N/A
  • URGN $39.80
  • Revenue Next Year
  • DSX $12.09
  • URGN $108.94
  • P/E Ratio
  • DSX $31.26
  • URGN N/A
  • Revenue Growth
  • DSX N/A
  • URGN 8.98
  • 52 Week Low
  • DSX $1.27
  • URGN $3.42
  • 52 Week High
  • DSX $2.86
  • URGN $17.00
  • Technical
  • Relative Strength Index (RSI)
  • DSX 59.05
  • URGN 66.88
  • Support Level
  • DSX $1.55
  • URGN $13.79
  • Resistance Level
  • DSX $1.66
  • URGN $15.24
  • Average True Range (ATR)
  • DSX 0.06
  • URGN 0.81
  • MACD
  • DSX 0.01
  • URGN -0.05
  • Stochastic Oscillator
  • DSX 86.36
  • URGN 82.74

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

Share on Social Networks: